{"nct_id":"NCT01652547","title":"A Phase I, Exploratory, Intra-patient Dose Escalation Study to Investigate the Preliminary Safety, Pharmacokinetics, and Anti-tumor Activity of Pasireotide (SOM230) s.c.Followed by Pasireotide LAR in Patients With Metastaticmelanoma or Metastatic Merkel Cell Carcinoma","status":"COMPLETED","status_verified_date":"2016-03","start_date":"2012-11","start_date_type":null,"primary_completion_date":"2015-04","primary_completion_date_type":"ACTUAL","completion_date":"2015-04","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["NVS"]}